Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration.
Publication
, Journal Article
Chieh, JJ; Fekrat, S
Published in: Ann Ophthalmol (Skokie)
2007
We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular age-related macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.
Duke Scholars
Published In
Ann Ophthalmol (Skokie)
DOI
EISSN
1558-9951
Publication Date
2007
Volume
39
Issue
1
Start / End Page
51 / 52
Location
United States
Related Subject Headings
- Vitreous Body
- Vision Disorders
- Retinal Hemorrhage
- Ophthalmology & Optometry
- Male
- Macular Degeneration
- Humans
- Drug Administration Routes
- Bevacizumab
- Antibodies, Monoclonal, Humanized
Citation
APA
Chicago
ICMJE
MLA
NLM
Chieh, J. J., & Fekrat, S. (2007). Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration. Ann Ophthalmol (Skokie), 39(1), 51–52. https://doi.org/10.1007/BF02697326
Chieh, Jenet J., and Sharon Fekrat. “Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration.” Ann Ophthalmol (Skokie) 39, no. 1 (2007): 51–52. https://doi.org/10.1007/BF02697326.
Chieh JJ, Fekrat S. Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration. Ann Ophthalmol (Skokie). 2007;39(1):51–2.
Chieh, Jenet J., and Sharon Fekrat. “Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration.” Ann Ophthalmol (Skokie), vol. 39, no. 1, 2007, pp. 51–52. Pubmed, doi:10.1007/BF02697326.
Chieh JJ, Fekrat S. Large subretinal hemorrhage after intravitreal bevacizumab (Avastin) for age-related macular degeneration. Ann Ophthalmol (Skokie). 2007;39(1):51–52.
Published In
Ann Ophthalmol (Skokie)
DOI
EISSN
1558-9951
Publication Date
2007
Volume
39
Issue
1
Start / End Page
51 / 52
Location
United States
Related Subject Headings
- Vitreous Body
- Vision Disorders
- Retinal Hemorrhage
- Ophthalmology & Optometry
- Male
- Macular Degeneration
- Humans
- Drug Administration Routes
- Bevacizumab
- Antibodies, Monoclonal, Humanized